Leyden Labs
Develop broad-spectrum, self-administered, intranasal antiviral drugs to prevent infection. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$560—840m (Dealroom.co estimates Jan 2022.)
Company register number 78220521
Amsterdam North Holland (HQ)
Authorizing premium user...